Navigation Links
Halt Uterine Fibroid Study Attracts National Media Attention
Date:2/1/2010

LIVERMORE, Calif., Feb. 1 /PRNewswire/ -- The Wall Street Journal, CBS, and other popular news outlets have recently featured headline stories about a clinical study that is recruiting patients suffering with uterine fibroids.  "We're not at all surprised by the attention this study is getting from the media," said Russ DeLonzor, President and Chief Operating Officer of Halt Medical, Inc., a medical technology company headquartered near San Francisco.  Fibroids are benign tumors of the uterus that cause serious, debilitating symptoms including heavy menstrual bleeding, severe cramping, urinary problems, and painful intercourse. Currently the only cure that the gynecologist can offer to patients with fibroids involves major surgery.  "Each year nearly 250,000 women in the US undergo radical surgery to remove their entire uterus rather than to continue suffering with their fibroid symptoms," according to Mr. DeLonzor.  About 8 million women have fibroids, or leiomyomas of the uterus.  "So many lives are impacted in some way by fibroids.  It's no surprise that a clinical study of an outpatient procedure which targets the fibroids while sparing the uterus would gain such widespread attention from the media."   Details of who may qualify for the Halt Uterine Fibroid Study and participating clinical sites are available through the National Institutes of Health at:  clinicaltrials.gov/ct2/show/NCT00874029

SOURCE Halt Medical, Inc.


'/>"/>
SOURCE Halt Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Gorilla Receives State-Of-The-Art Treatment for Uterine Fibroids from Interventional Radiologists
2. Society of Gynecologic Oncologists Provides Guidelines for Offering Genetic Risk Assessment to Women With a Personal or Family History of Breast, Ovarian, Uterine or Colorectal Cancer
3. Few Women Hear About Uterine Fibroid Embolization Treatment Option Directly From Gynecologists
4. UFE Highly Effective in Cases Where Focused Ultrasound to Treat Uterine Fibroids Failed
5. Major surgery no longer needed for the removal of uterine fibroids
6. Scientists ID Uterine Muscle Switch for Contractions
7. Black women with uterine cancers more likely to die than white patients
8. Gene Variant Raises Risk of Uterine Fibroids
9. Prominent Chicago Gynecologists Launch Treatment Project To Raise Awareness Among African American Women of Non-Invasive Ultrasound Uterine Fibroid Procedure
10. Singapore Premier Women's Hospital Offers Contactless Surgery for Uterine Fibroids
11. Chamberlain Group Announces New Uterine Robotic Surgery Training Device
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/13/2016)... ... February 13, 2016 , ... When an Au Pair comes all the way ... they are in for and they are often worried things won’t go well. More often ... for. This year’s Au Pair of the Year winner’s all commented how their Au Pairs ...
(Date:2/12/2016)... ... February 12, 2016 , ... According to an ... beginning to account for a significant portion of hernia repairs throughout the United States. ... Beverly Hills Hernia Center notes that this trend has not only been expected, but ...
(Date:2/12/2016)... WA, and Washington, DC (PRWEB) , ... ... ... PATH and the Siemens Foundation today announced a new initiative—the Siemens Foundation-PATH ... for low-resource settings. The partnership will recruit top students from U.S. universities ...
(Date:2/12/2016)... ... February 12, 2016 , ... Fixed Dose Combination ... 3:00 p.m. EST, http://www.fdanews.com/fixeddosecombination , Fixed dose combination ... garnering increased attention from all stakeholders in the development of new chemical entities. ...
(Date:2/12/2016)... CULVER CITY, California (PRWEB) , ... February 12, 2016 , ... ... to announce their participation in Red Carpet Events LA GRAMMY’s Style Lounge Event. Coco ... and healthy way to stay hydrated before the big event. The invitation-only gifting suite, ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... 12, 2016  Aralez Pharmaceuticals Inc. (Nasdaq: ARLZ ... Company will ring the Nasdaq Closing Bell at the ... at 4:00 p.m. ET on Tuesday, February ... Adrian Adams , will perform the honorary ... 4:00 p.m. ET.  A live webcast will be available ...
(Date:2/12/2016)... Ungarn, February 12, 2016 ... sich auf den ungedeckten medizinischen Bedarf bei ... Ergebnisse seines klinischen Forschungsprogramms bekannt. Das Programm, ... ergab Verbesserungen ihrer respiratorischen Funktionen und anderer ... , ein Medizintechnikunternehmen, das sich auf den ...
(Date:2/11/2016)... , Feb. 11, 2016 Stem cells ... are characterized by self-renewal and the capacity to differentiate ... relatively new discovery, as the first mouse embryonic stem ... was not until 1995 that the first culturing of ... stem cells were not produced until 2006 As a ...
Breaking Medicine Technology: